MA27442A1 - Derives de triazole servant d'inhibiteurs du facteur de croissance transformant (tgf) - Google Patents
Derives de triazole servant d'inhibiteurs du facteur de croissance transformant (tgf)Info
- Publication number
- MA27442A1 MA27442A1 MA28156A MA28156A MA27442A1 MA 27442 A1 MA27442 A1 MA 27442A1 MA 28156 A MA28156 A MA 28156A MA 28156 A MA28156 A MA 28156A MA 27442 A1 MA27442 A1 MA 27442A1
- Authority
- MA
- Morocco
- Prior art keywords
- tgf
- growth factor
- transforming growth
- triazole derivatives
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Abstract
DEPOSANT Société dite : PFIZER PRODUCTS INC. REVENDICATION DE PRIORITES US 18 Septembre 2002 60/412,079 US 2 Juillet 2003 60/484,535 Voir en annexe le titre de l'invention et le texte de l'abrégé Dérivés de triazole servant d'inhibiteurs du facteur de croissance transformant Des dérivés de triazole nouveaux de formule (Ia-c), des intermédiaires pour leur préparation, des compositions pharmaceutiques les contenant et leur utilisation en médecine sont décrits. Les composés de la présente invention sont de puissants inhibiteurs de la voie de transmission de signal du facteur de croissance transformant ("TGF")-(bêta). Ils sont utiles dans le traitement de divers états pathologiques en rapport avec le TGF comprenant, par exemple, le cancer et des maladies fibrotiques.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41207902P | 2002-09-18 | 2002-09-18 | |
US48453503P | 2003-07-02 | 2003-07-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA27442A1 true MA27442A1 (fr) | 2005-07-01 |
Family
ID=32033582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA28156A MA27442A1 (fr) | 2002-09-18 | 2005-03-18 | Derives de triazole servant d'inhibiteurs du facteur de croissance transformant (tgf) |
Country Status (25)
Country | Link |
---|---|
US (2) | US7053095B2 (fr) |
EP (1) | EP1542685A1 (fr) |
JP (1) | JP2006502236A (fr) |
KR (1) | KR20050057393A (fr) |
CN (1) | CN1681502A (fr) |
AP (1) | AP2005003260A0 (fr) |
AR (1) | AR041276A1 (fr) |
AU (1) | AU2003260810A1 (fr) |
BR (1) | BR0314577A (fr) |
CA (1) | CA2497971A1 (fr) |
CO (1) | CO5540390A2 (fr) |
EA (1) | EA200500376A1 (fr) |
EC (1) | ECSP055681A (fr) |
HR (1) | HRP20050251A2 (fr) |
IS (1) | IS7713A (fr) |
MA (1) | MA27442A1 (fr) |
MX (1) | MXPA05002982A (fr) |
NO (1) | NO20051010L (fr) |
OA (1) | OA12927A (fr) |
PA (1) | PA8583401A1 (fr) |
PE (1) | PE20050074A1 (fr) |
PL (1) | PL375974A1 (fr) |
TW (1) | TW200412346A (fr) |
UY (1) | UY27981A1 (fr) |
WO (1) | WO2004026307A1 (fr) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY140679A (en) | 2001-05-24 | 2010-01-15 | Avanir Pharmaceuticals | Inhibitors of macrohage migration inhibitory factor and methods for identifying the same |
JP4547271B2 (ja) | 2002-09-18 | 2010-09-22 | ファイザー・プロダクツ・インク | トランスフォーミング増殖因子(tgf)阻害剤としての新規イミダゾール化合物 |
WO2004026863A1 (fr) | 2002-09-18 | 2004-04-01 | Pfizer Products Inc. | Nouveaux composes de triazole et d'oxazole, inhibiteurs du facteur de croissance transformant |
AP2005003263A0 (en) | 2002-09-18 | 2005-03-31 | Pfizer Prod Inc | Pyrazole derivatives as transforming growth factor(TGF) inhibitors. |
PA8595001A1 (es) | 2003-03-04 | 2004-09-28 | Pfizer Prod Inc | Nuevos compuestos heteroaromaticos condensados que son inhibidores del factor de crecimiento transforante (tgf) |
EP1854789B1 (fr) | 2005-02-23 | 2013-10-09 | Shionogi & Co., Ltd. | Derive de quinazoline possedant une activite inhibitrice vis-a-vis de la tyrosine kinase |
CA2614919C (fr) | 2005-07-25 | 2015-06-23 | Zachary Demko | Inhibiteurs de 1, 2, 3 triazoles de polymerisation de la tubuline pour le traitement des troubles proliferants |
AU2006325706B2 (en) * | 2005-12-16 | 2012-03-29 | Novartis Ag | Control of intraocular pressure using ALK5 modulation agents |
DE102005061840A1 (de) | 2005-12-23 | 2007-06-28 | Merck Patent Gmbh | Triazolderivate |
WO2008009078A2 (fr) | 2006-07-20 | 2008-01-24 | Gilead Sciences, Inc. | Dérivés de la quinazoline tri-substitués en 4,6-dl et en 2,4,6 utilisables pour traiter les infections virales |
US8673929B2 (en) | 2006-07-20 | 2014-03-18 | Gilead Sciences, Inc. | 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections |
US8871744B2 (en) | 2010-07-21 | 2014-10-28 | B & G Partyers, LLC | Compounds and methods for selectively targeting tumor-associated mucins |
WO2013078286A1 (fr) | 2011-11-22 | 2013-05-30 | Cornell University | Procédés destinés à stimuler le rétablissement hématopoïétique par inhibition de la signalisation tgf bêta |
EA032679B1 (ru) | 2012-10-05 | 2019-07-31 | Кадмон Корпорейшн, Ллк | Человеческие анти-vegfr-2/kdr-антитела |
PT3702443T (pt) | 2013-03-14 | 2022-02-17 | Massachusetts Inst Technology | Composições e métodos para expansão e cultura de células estaminais epiteliais |
PT3089971T (pt) | 2014-01-01 | 2020-09-03 | Medivation Tech Llc | Compostos e métodos de utilização |
KR20230019500A (ko) | 2014-09-03 | 2023-02-08 | 더 브리검 앤드 우먼즈 하스피털, 인크. | 청력 손실의 치료를 위해 내이 털세포를 생성하기 위한 조성물, 시스템, 및 방법 |
PL3097102T3 (pl) | 2015-03-04 | 2018-04-30 | Gilead Sciences Inc | Związki 4,6-diamino-pirydo[3,2-d]pirymidyny modulujące działanie receptora toll-podobnego |
JP2019506153A (ja) | 2016-01-08 | 2019-03-07 | マサチューセッツ インスティテュート オブ テクノロジー | 分化した腸内分泌細胞およびインスリン産生細胞の作製 |
US10201540B2 (en) | 2016-03-02 | 2019-02-12 | Frequency Therapeutics, Inc. | Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: I |
US11260130B2 (en) | 2016-03-02 | 2022-03-01 | Frequency Therapeutics, Inc. | Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using a GSK3 inhibitor: IV |
US10213511B2 (en) | 2016-03-02 | 2019-02-26 | Frequency Therapeutics, Inc. | Thermoreversible compositions for administration of therapeutic agents |
EP3507276B1 (fr) | 2016-09-02 | 2021-11-03 | Gilead Sciences, Inc. | Composés modulateurs du recepteur de type toll |
EP3507288B1 (fr) | 2016-09-02 | 2020-08-26 | Gilead Sciences, Inc. | Dérivés de 4,6-diamino-pyrido[3,2-d]pyrimidine en tant que modulateurs du recepteur de type toll |
US11066419B2 (en) | 2016-12-30 | 2021-07-20 | Frequency Therapeutics, Inc. | 1H-pyrrole-2,5-dione compounds and methods of using same |
CA3093340A1 (fr) | 2018-03-20 | 2019-09-26 | Icahn School Of Medicine At Mount Sinai | Composes inhibiteurs de kinase, compositions et procedes d'utilisation |
US20210309679A1 (en) | 2018-07-23 | 2021-10-07 | Guangzhou Othrotx Co., Ltd. | Bisphosphonate drug conjugates |
CN113195707A (zh) | 2018-08-17 | 2021-07-30 | 频率治疗公司 | 用于通过上调jag-1来生成毛细胞的组合物和方法 |
WO2020037326A1 (fr) | 2018-08-17 | 2020-02-20 | Frequency Therapeutics, Inc. | Compositions et méthodes pour produire des cellules ciliées par la régulation à la baisse de foxo |
US20220162182A1 (en) | 2018-12-31 | 2022-05-26 | Icahn School Of Medicine At Mount Sinai | Kinase inhibitor compounds and compositions and methods of use |
TW202210480A (zh) | 2019-04-17 | 2022-03-16 | 美商基利科學股份有限公司 | 類鐸受體調節劑之固體形式 |
TW202212339A (zh) | 2019-04-17 | 2022-04-01 | 美商基利科學股份有限公司 | 類鐸受體調節劑之固體形式 |
TW202115056A (zh) | 2019-06-28 | 2021-04-16 | 美商基利科學股份有限公司 | 類鐸受體調節劑化合物的製備方法 |
CN112694477B (zh) * | 2019-10-22 | 2024-02-06 | 四川科伦博泰生物医药股份有限公司 | 吡唑并环类化合物,包含其的药物组合物,其制备方法及其用途 |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6058981A (ja) * | 1983-09-09 | 1985-04-05 | Takeda Chem Ind Ltd | 5−ピリジル−1,3−チアゾ−ル誘導体,その製造法およびそれを含んでなる医薬組成物 |
JPS6025142A (ja) | 1983-07-21 | 1985-02-07 | Matsushita Electric Ind Co Ltd | 表示装置の電極製造方法 |
DE3486009T2 (de) * | 1983-09-09 | 1993-04-15 | Takeda Chemical Industries Ltd | 5-pyridyl-1,3-thiazol-derivate, ihre herstellung und anwendung. |
GB9201692D0 (en) * | 1992-01-27 | 1992-03-11 | Smithkline Beecham Intercredit | Compounds |
BR9809451A (pt) | 1997-05-22 | 2000-06-20 | Searle & Co | Pirazóis substituìdos com 3(5)-heteroarila como inibidores de quinase p38. |
JP2002502380A (ja) | 1997-05-22 | 2002-01-22 | ジー.ディー.サール アンド カンパニー | p38キナーゼ阻害剤としてのピラゾール誘導体 |
US6514977B1 (en) | 1997-05-22 | 2003-02-04 | G.D. Searle & Company | Substituted pyrazoles as p38 kinase inhibitors |
EP1027050B1 (fr) * | 1997-10-27 | 2004-01-14 | Takeda Chemical Industries, Ltd. | 1,3-thiazoles comme antagonistes des recepteurs de l'adenosine a3 pour le traitement de l'allergie, de l'asthme et du diabete |
US6465493B1 (en) | 1999-04-09 | 2002-10-15 | Smithkline Beecham Corporation | Triarylimidazoles |
JP2000302680A (ja) * | 1999-04-23 | 2000-10-31 | Takeda Chem Ind Ltd | 脳保護剤 |
AU6471300A (en) * | 1999-08-06 | 2001-03-05 | Takeda Chemical Industries Ltd. | P38map kinase inhibitors |
CO5271680A1 (es) | 2000-02-21 | 2003-04-30 | Smithkline Beecham Corp | Compuestos |
GB0007405D0 (en) | 2000-03-27 | 2000-05-17 | Smithkline Beecham Corp | Compounds |
PE20020506A1 (es) | 2000-08-22 | 2002-07-09 | Glaxo Group Ltd | Derivados de pirazol fusionados como inhibidores de la proteina cinasa |
JP2004517068A (ja) | 2000-11-16 | 2004-06-10 | スミスクライン・ビーチャム・コーポレイション | 化合物 |
GB0027987D0 (en) | 2000-11-16 | 2001-01-03 | Smithkline Beecham Plc | Compounds |
EP1354603A1 (fr) * | 2000-12-26 | 2003-10-22 | Takeda Chemical Industries, Ltd. | Co-prescriptions |
GB0100762D0 (en) | 2001-01-11 | 2001-02-21 | Smithkline Beecham Plc | Novel use |
GB0102665D0 (en) * | 2001-02-02 | 2001-03-21 | Glaxo Group Ltd | Compounds |
GB0102672D0 (en) | 2001-02-02 | 2001-03-21 | Glaxo Group Ltd | Compounds |
ES2237671T3 (es) | 2001-02-02 | 2005-08-01 | Smithkline Beecham Corporation | Derivados de pirazol contra la sobreexpresion de tgf. |
US20040097502A1 (en) | 2001-02-02 | 2004-05-20 | Gellibert Francoise Jeanne | Pyrazoles as tgf inhibitors |
GB0102673D0 (en) * | 2001-02-02 | 2001-03-21 | Glaxo Group Ltd | Compounds |
GB0102668D0 (en) * | 2001-02-02 | 2001-03-21 | Glaxo Group Ltd | Compounds |
US20040077697A1 (en) * | 2001-02-02 | 2004-04-22 | Hiroyuki Koshio | 2-Acylaminothiazole derivative or its salt |
US20050080113A1 (en) * | 2001-06-11 | 2005-04-14 | Shigenori Ohkawa | Medicinal compositions |
AR039241A1 (es) | 2002-04-04 | 2005-02-16 | Biogen Inc | Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos |
GB0217780D0 (en) | 2002-07-31 | 2002-09-11 | Glaxo Group Ltd | Compounds |
JP2005539000A (ja) | 2002-07-31 | 2005-12-22 | スミスクライン・ビーチャム・コーポレイション | Alk5阻害剤としての2−フェニルピリジン−4−イル誘導体 |
-
2003
- 2003-09-08 OA OA1200500076A patent/OA12927A/en unknown
- 2003-09-08 WO PCT/IB2003/003825 patent/WO2004026307A1/fr active Application Filing
- 2003-09-08 CA CA002497971A patent/CA2497971A1/fr not_active Abandoned
- 2003-09-08 JP JP2004568900A patent/JP2006502236A/ja not_active Abandoned
- 2003-09-08 AU AU2003260810A patent/AU2003260810A1/en not_active Abandoned
- 2003-09-08 EP EP03797428A patent/EP1542685A1/fr not_active Withdrawn
- 2003-09-08 AP AP2005003260A patent/AP2005003260A0/xx unknown
- 2003-09-08 CN CNA038221594A patent/CN1681502A/zh active Pending
- 2003-09-08 PL PL03375974A patent/PL375974A1/xx not_active Application Discontinuation
- 2003-09-08 MX MXPA05002982A patent/MXPA05002982A/es unknown
- 2003-09-08 BR BR0314577-8A patent/BR0314577A/pt not_active IP Right Cessation
- 2003-09-08 EA EA200500376A patent/EA200500376A1/ru unknown
- 2003-09-08 KR KR1020057004575A patent/KR20050057393A/ko not_active Application Discontinuation
- 2003-09-16 UY UY27981A patent/UY27981A1/es not_active Application Discontinuation
- 2003-09-16 PE PE2003000947A patent/PE20050074A1/es not_active Application Discontinuation
- 2003-09-16 AR ARP030103360A patent/AR041276A1/es unknown
- 2003-09-17 US US10/667,183 patent/US7053095B2/en not_active Expired - Fee Related
- 2003-09-17 TW TW092125634A patent/TW200412346A/zh unknown
- 2003-09-17 PA PA20038583401A patent/PA8583401A1/es unknown
-
2005
- 2005-02-24 IS IS7713A patent/IS7713A/is unknown
- 2005-02-24 NO NO20051010A patent/NO20051010L/no unknown
- 2005-03-16 CO CO05024528A patent/CO5540390A2/es not_active Application Discontinuation
- 2005-03-17 HR HR20050251A patent/HRP20050251A2/hr not_active Application Discontinuation
- 2005-03-17 EC EC2005005681A patent/ECSP055681A/es unknown
- 2005-03-18 MA MA28156A patent/MA27442A1/fr unknown
-
2006
- 2006-02-07 US US11/349,481 patent/US20060128761A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AP2005003260A0 (en) | 2005-03-31 |
US20060128761A1 (en) | 2006-06-15 |
AR041276A1 (es) | 2005-05-11 |
US7053095B2 (en) | 2006-05-30 |
US20040110798A1 (en) | 2004-06-10 |
TW200412346A (en) | 2004-07-16 |
EA200500376A1 (ru) | 2005-08-25 |
ECSP055681A (es) | 2005-05-30 |
BR0314577A (pt) | 2005-08-09 |
WO2004026307A1 (fr) | 2004-04-01 |
UY27981A1 (es) | 2004-04-30 |
CA2497971A1 (fr) | 2004-04-01 |
AU2003260810A1 (en) | 2004-04-08 |
CN1681502A (zh) | 2005-10-12 |
JP2006502236A (ja) | 2006-01-19 |
EP1542685A1 (fr) | 2005-06-22 |
IS7713A (is) | 2005-02-24 |
CO5540390A2 (es) | 2005-07-29 |
MXPA05002982A (es) | 2005-06-22 |
NO20051010L (no) | 2005-05-31 |
HRP20050251A2 (en) | 2005-10-31 |
PA8583401A1 (es) | 2004-04-23 |
KR20050057393A (ko) | 2005-06-16 |
PE20050074A1 (es) | 2005-03-21 |
OA12927A (en) | 2006-10-13 |
PL375974A1 (en) | 2005-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA27442A1 (fr) | Derives de triazole servant d'inhibiteurs du facteur de croissance transformant (tgf) | |
MA27441A1 (fr) | Composes d'imidazole nouveaux servant d'inhibiteurs du facteur de croissance transformant (tgf) | |
MA27440A1 (fr) | Derives de pyrazole servant d'inhibiteurs du facteur de croissance transformant(tgf) | |
MA27444A1 (fr) | Derives d'isothiazole et d'isoxazole nouveaux servant d'inhibiteurs du facteur de croissance transformant (tgf) | |
MA27443A1 (fr) | Oxazoles et thiazoles nouveaux servant d'inhibiteurs du facteur de croissance transformant (tgf) | |
MA27451A1 (fr) | Derives de thiazole pour le traitement de troubles neurodegeneratifs | |
MXPA05009245A (es) | Nuevos compuestos de pirazina como inhibidores del factor de crecimiento transformante (tgf). | |
MA27144A1 (fr) | Benzamide et heteroarylamide servant d'antagonistes du recepteur p2x7 | |
NZ542622A (en) | Solid pharmaceutical compositions comprising a S1P receptor agonist and a sugar alcohol | |
MA26861A1 (fr) | Inhibiteurs non peptidiques de la liaison cellulaire sous la dependance de vla-4 utiles dans le traitement des maladies inflammatoires, auto-immunes et respiratoires | |
MA27661A1 (fr) | Indolone-oxazolidinones antibacteriennes, intermediaires pour leur preparation et compositions pharmaceutiques les contenant | |
MA27093A1 (fr) | Derives de sulfonamides, leur preparation et leur application comme medicaments. | |
MA26946A1 (fr) | Derives de pyrazole nouveaux et leur utilisation comme inhibiteurs de proteine-kinases. | |
MXPA05008148A (es) | Nuevos compuestos heteroaromaticos condensados que son inhibidores del factor de crecimiento transformante (tgf). | |
MA27840A1 (fr) | Derives de (2-hydroxy-2-(4-hydroxy-3-hydroxymethylphenyl)-ethylamino)-propylphenyle servant d'agonistes beta2 | |
MA27867A1 (fr) | Nouveaux derives de 2h-pyridazine-3-one, compositions pharmaceutiques contenant ces derives et procede de preparation de l'ingredient actif. | |
MA27095A1 (fr) | Formes de sels de e-2 -methoxy-n-(3-(4-(3-methyl-pyridine-3-yloxy)-phenylamino)-quinazoline-6-yl)-allyl)-acetamide, leur preparation et leur utilisation contre le cancer | |
WO1982001821A1 (fr) | Composition pharmaceutiques antimycotiques synergiques et leur procede de preparation | |
AP1408A (en) | Phenyl yanthine derivatives. | |
MA26690A1 (fr) | COMPOSITIONS PHARMACEUTIQUES CONTENANT DES DERIVES DE PYRIDO [1,2-a ] PYRAZINE ET PROCEDE POUR LEUR PREPARATION | |
MA27676A1 (fr) | 2-amino-6-(2-substitue-4-phenoxy)-substitue-pyridines, procede pour leur preparation et compositions pharmaceutiques les contenant | |
MA26701A1 (fr) | PYRAZOLOPYRIMIDINONES NOUVELLES INHIBITRICES DE PDE-5 GMPc, PROCEDE POUR LEUR PREPARATION ET COMPOSTIONS PHARMACEUTIQUES LES CONTENANT. | |
NZ304291A (en) | Trisubstituted phenyl derivatives, preparation and pharmaceutical compositions thereof | |
MA26953A1 (fr) | Derives de pipérazine pontés. | |
KR101577792B1 (ko) | 마치현 추출물 또는 이의 분획물을 유효성분으로 포함하는 il-6 매개성 질환의 예방 또는 치료용 약학적 조성물 |